The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
| |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 37,999,916 | 1,142,511 | SH | SOLE | 1,142,511 | 0 | 0 | ||
ALKERMES PLC | SHS | G01767105 | 39,355,029 | 1,375,569 | SH | SOLE | 1,375,569 | 0 | 0 | ||
APOGEE THERAPEUTICS INC | COM | 03770N101 | 41,633,301 | 958,630 | SH | SOLE | 958,630 | 0 | 0 | ||
ARCELLX INC | COMMON STOCK | 03940C100 | 306,137,704 | 4,649,016 | SH | SOLE | 4,649,016 | 0 | 0 | ||
BEONE MEDICINES LTD | SPONSORED ADS | 07725L102 | 84,188,799 | 347,787 | SH | SOLE | 347,787 | 0 | 0 | ||
BRIDGEBIO PHARMA INC | COM | 10806X102 | 41,701,690 | 965,764 | SH | SOLE | 965,764 | 0 | 0 | ||
COGENT BIOSCIENCES INC | COM | 19240Q201 | 74,330,584 | 10,352,449 | SH | SOLE | 10,352,449 | 0 | 0 | ||
CRESCENT BIOPHARMA INC. | COM | G2545C104 | 10,373,517 | 642,721 | SH | SOLE | 642,721 | 0 | 0 | ||
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 67,400,584 | 2,343,553 | SH | SOLE | 2,343,553 | 0 | 0 | ||
DISC MEDICINE INC | COM | 254604101 | 64,133,024 | 1,210,971 | SH | SOLE | 1,210,971 | 0 | 0 | ||
EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 80,526,130 | 6,142,344 | SH | SOLE | 6,142,344 | 0 | 0 | ||
ERASCA INC | COM | 29479A108 | 15,122,121 | 11,907,182 | SH | SOLE | 11,907,182 | 0 | 0 | ||
IMMATICS N.V | SHS | N44445109 | 16,915,565 | 3,144,157 | SH | SOLE | 3,144,157 | 0 | 0 | ||
JANUX THERAPEUTICS INC | COM | 47103J105 | 67,457,960 | 2,920,258 | SH | SOLE | 2,920,258 | 0 | 0 | ||
LENZ THERAPEUTICS INC | COM | 52635N103 | 50,327,204 | 1,717,066 | SH | SOLE | 1,717,066 | 0 | 0 | ||
MERUS N V | COM | N5749R100 | 225,230,780 | 4,281,954 | SH | SOLE | 4,281,954 | 0 | 0 | ||
MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | 41,456,846 | 878,323 | SH | SOLE | 878,323 | 0 | 0 | ||
NUVALENT INC | COM | 670703107 | 402,057,738 | 5,269,433 | SH | SOLE | 5,269,433 | 0 | 0 | ||
OCULAR THERAPEUTIX INC | COM | 67576A100 | 31,740,755 | 3,420,340 | SH | SOLE | 3,420,340 | 0 | 0 | ||
OLEMA PHARMACEUTICALS INC | COM | 68062P106 | 28,815,373 | 6,764,172 | SH | SOLE | 6,764,172 | 0 | 0 | ||
PHARVARIS N V | COM | N69605108 | 18,707,234 | 1,062,911 | SH | SOLE | 1,062,911 | 0 | 0 | ||
REVOLUTION MEDICINES INC | COM | 76155X100 | 224,172,176 | 6,093,291 | SH | SOLE | 6,093,291 | 0 | 0 | ||
SCHOLAR ROCK HLDG CORP | COM | 80706P103 | 56,691,623 | 1,600,554 | SH | SOLE | 1,600,554 | 0 | 0 | ||
SPYRE THERAPEUTICS INC | COM NEW | 00773J202 | 28,000,562 | 1,870,445 | SH | SOLE | 1,870,445 | 0 | 0 | ||
TARSUS PHARMACEUTICALS INC | COM | 87650L103 | 120,561,770 | 2,976,099 | SH | SOLE | 2,976,099 | 0 | 0 | ||
VAXCYTE INC | COM | 92243G108 | 109,650,931 | 3,372,837 | SH | SOLE | 3,372,837 | 0 | 0 | ||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 38,327,232 | 2,741,576 | SH | SOLE | 2,741,576 | 0 | 0 | ||
Y-MABS THERAPEUTICS INC | COM | 984241109 | 19,105,920 | 4,236,346 | SH | SOLE | 4,236,346 | 0 | 0 |